Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Carboxylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110305010A details a green Grignard route for 2 5-dimethylphenylacetic acid. This method eliminates toxic cyanide and noble metals, ensuring cost reduction and supply reliability.
Patent CN101679156A details a novel decarboxylation process for fluoroalkyl alcohols using amine catalysts, offering high selectivity and cost-effective manufacturing solutions.
Novel two-step synthesis for Repaglinide intermediate offering high purity, recyclable solvents, and significant cost reduction in API manufacturing.
Patent CN110292948B reveals a metal-free carboxylation method using imidazole salts, offering safer atmospheric pressure synthesis for pharmaceutical intermediates.
Patent CN111777477A details a mild visible-light method for synthesizing succinic acid derivatives and 3-arylpropionic acids using CO2, offering significant cost and safety advantages.
Patent CN102241679B details selective decarboxylation for Midazolam. Enhances purity and supply chain reliability for global pharmaceutical intermediate manufacturing partners.
Patent CN107778155B details a green Fe3O4-catalyzed decarboxylation route for photoinitiator intermediates, offering significant cost reduction and supply chain reliability.
Patent CN101955415A details a high-yield route to 2-hydroxybiphenyl using 9-fluorenone. This method offers significant cost reduction and supply chain reliability for fine chemical intermediates.
Patent CN101955415B details a high-yield route for 2-hydroxyl biphenyl using 9-fluorenone. Discover cost-effective manufacturing and supply chain advantages.
Patent CN108752232B details a green photocatalytic method for alpha-quaternary amino acids using CO2, offering safer alternatives to toxic Strecker reactions for pharma supply chains.
Novel green synthesis route for fluoroquinolone intermediates offering high purity and scalable production capabilities for global pharma supply chains.
Novel TEMPO-catalyzed route for 20-keto steroids eliminates toxic DMS and expensive reagents, offering cost-effective manufacturing for corticosteroids.
Patent CN116947650A reveals a novel decarboxylation route for cyclopropylamine. Discover cost reduction in pharmaceutical intermediates manufacturing and high-purity production capabilities.
Patent CN116354829B details a novel L-lysine decarboxylation route for high-purity pentamethylenediamine adipate, offering significant cost reduction in polymers & plastics manufacturing.
Patent CN118666861A reveals a 2-step route for 2,5-dioxaspiro[3,4]octan-7-one. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN102126977A reveals a novel gas-phase catalytic carboxylation method for 5-ASA production, offering superior yield, purity, and environmental compliance for pharmaceutical supply chains.
Patent CN1934063A details a palladium-catalyzed decarboxylation route for pyrethroid intermediates, offering significant cost reduction and supply chain reliability.
Patent CN110746334A details a 4-step synthesis of 3-(3-chloropropyl)-4-oxopyrrolidine-1-carboxylate, offering high yield and reduced waste for API manufacturing.
Patent CN120923436A reveals a low-cost synthesis route for Fluralaner intermediates. Enhance supply chain reliability and purity with scalable veterinary drug solutions.
Patent CN113416166B details a green silver-catalyzed route using CO2 and ionic liquids for high-purity pharmaceutical intermediates with simplified workup.